SCHEMBL22997451

SCHEMBL22997451

Clc1ccc(C2=C3CNC=CN3C(C3CCOCC3)N2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22997636 0.79 MAPT (0.35) —
SCHEMBL22997452 0.66 APOBEC3G (0.31) —
SCHEMBL22997003 0.61 SLC2A1 (0.38) —
SCHEMBL22997165 0.59 PSD (0.37) —
SCHEMBL22997002 0.57 GSK3B (0.36) —
SCHEMBL25247362 0.53 HTR3A (0.48) —
SCHEMBL17086550 0.51 BCL2A1 (0.49) —
SCHEMBL21254366 0.51 BCL2A1 (0.49) —
SCHEMBL27809659 0.50 HTR3A (0.46) —
SCHEMBL315185 0.50 LMNA (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3777846-A1 VAP-1 INHIBITORS FOR TREATING PAIN BenevolentAI Cambridge Limited (GB) 2021-02-17 — — EP disclosed
Send feedback